Shop Now
RST-SANEXAS NeoGEN Neuropathy
Home » RST-SANEXAS NeoGEN Neuropathy

RST-SANEXAS NeoGEN Neuropathy

$8.500

The neoGEN Electrical Cell Signaling System is a non-invasive therapeutic device that delivers advanced bio-electrical waveforms to support pain relief, improve circulation, and enhance neuromuscular function. Designed for clinics and rehabilitation centers, it uses patented electric cell-signaling technology to aid recovery from chronic pain, neuropathy, and musculoskeletal conditions.

Category:

Description

RST-SANEXAS neoGEN® Neuropathy Pain Treatment System

The Synaptic neoGEN® System is an advanced electrical cell signaling technology (EST) device designed for the treatment of neuropathy and chronic pain. Utilizing cutting-edge bio-electrical stimulation, the NeoGEN system promotes natural nerve cell communication and helps restore normal nerve function, offering patients a non-invasive, drug-free alternative to pain management.

Manufactured and developed by RST-SANEXAS this system delivers multiple therapeutic frequencies to stimulate deep cellular repair and improve microcirculation addressing the root cause of neuropathic pain rather than masking symptoms. The result is a safe, comfortable, and highly effective therapy for patients suffering from diabetic neuropathy, chronic pain, and nerve disorders.

Key Features:

  • Electrical Cell Signaling Therapy (EST) – Uses patented waveforms to restore nerve cell communication and function.

  • Multi-Frequency Stimulation – Targets deep and superficial tissues for comprehensive pain relief.

  • Non-Invasive & Drug-Free – Provides safe therapy without medications, injections, or surgery.

  • Patient-Friendly Design – Delivers gentle electrical pulses for comfortable, relaxing treatments.

  • Clinically Proven Results – Shown to reduce pain, tingling, and numbness associated with peripheral neuropathy.

  • Versatile Clinical Use – Ideal for pain management, physical therapy, and neurology practices.

Applications:

  • Peripheral neuropathy (diabetic, idiopathic, chemotherapy-induced)

  • Chronic pain and nerve damage

  • Circulatory and neuromuscular disorders

  • Painful sensory neuropathy

  • Post-surgical and injury-related nerve pain

Technical Highlights:

  • Technology: Electrical Cell Signaling (EST)

  • Frequency range: Variable, multi-waveform output

  • Output channels: Dual or multi-site therapy capability

  • Interface: Digital touchscreen with pre-set treatment protocols

  • Safety: FDA-cleared, non-invasive medical device

Why Choose the neoGEN® System:

The neoGEN® Electrical Cell Signaling System represents the future of neuropathy and chronic pain therapy. By treating the underlying cause of nerve dysfunction through advanced bio-electrical stimulation, it empowers clinicians to deliver long-lasting pain relief and functional improvement safely and effectively.